Incidence, Outcomes and Risk Factors for Atrial Fibrillation in Patients With JAK2V617F‐Positive Myeloproliferative Neoplasms

Guangshuai Teng; Ke Shang; Yuhui Zhang; Yifan Duan; Chenxiao Du; Yan Wang; Yanqi Li; Huiqin Zhang; Lan Peng; Xiaojing Wei; Gary Tse; Yuan Zhou; Professor Gregory Lip; Tong Liu; Wei Yang; Minghui Duan; Jie Bai

doi:10.1002/cam4.71015

Back

Incidence, Outcomes and Risk Factors for Atrial Fibrillation in Patients With JAK2V617F‐Positive Myeloproliferative Neoplasms

Article 2025 en

Abstract

1 min read

AF was significantly associated with higher risks of stroke and mortality. TET2 mutation and increased IL-1β were independent risk factors of AF in patients with JAK2V617F-positive MPN.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk

Tze‐Fan Chao, Professor Gregory Lip, S.A Chen

Article2011

Abstract 8688: Incident Stroke and Mortality Associated with First-detected Atrial Fibrillation in Patients Hospitalized with Severe Sepsis

Allan J. Walkey, Renda Soylemez Wiener, Joanna Ghobrial, Lesley H. Curtis, Emelia Benjamin

Article2020

Relationship of particular matter and temperature on the risk of adverse events in atrial fibrillation patients

José Miguel Rivera‐Caravaca, Vanessa Roldán, Vicente Vicente, Professor Gregory Lip, Francisco Marı́n

Article2016

Oral anticoagulation, stroke and thromboembolism in patients with atrial fibrillation and valve bioprosthesis

Raphaël Philippart, Anne Brunet-Bernard, Nicolas Clémenty, Thierry Bourguignon, Alain Mirza, Denis Angoulvant, Dominique Babuty, Professor Gregory Lip, Laurent Fauchier

Article2023

Risk of incident atrial fibrillation and subsequent use of oral anticoagulants in patients with dementia

Tze‐Fan Chao, Ling Kuo, Professor Gregory Lip, S A Chen

Incidence, Outcomes and Risk Factors for Atrial Fibrillation in Patients With <i>JAK2<sup>V617F</sup></i>‐Positive Myeloproliferative Neoplasms